Details for 2021156398

Up to date per 03.04.2026

Actions

Title / Product Name

DEUTERIERTE DERIVATE VON RUXOLITINIB

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021156398

EP Publication Number

3882249

E-Number

1794739

Language

PCT Number

Publication Date

22.09.2021 A

14.05.2025 B1

Registration Date

14.05.2025

AT Publication Date

15.06.2025

Application Date

14.06.2013

Registration Number

Priorities

15.06.2012

201261660428 P

02.08.2012

201261678795 P

IPC

C07D 487/04 20060101AFI20210611BHEP

Maximum Duration of Protection

14.06.2033

Owner

Sun Pharmaceutical Industries, Inc.2 Independence Way Princeton, NJ 08540US

Representative

No representatives present

Inventor

Silverman, I. Robert36 Orvis Road Arlington, Massachusetts 02474US

Liu, Julie F.3 Whitman Circle Lexington, Massachusetts 02420US

Morgan, Adam J.14 Oak Ridge Lane Ashland, Massachusetts 01721US

Pandya, Bhaumik325 Springs Road Bedford, Massachusetts 01730US

Harbeson, Scott L.355 Shore Dr Ellenton, Florida 34222-2025US

Information about Fees